# Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation

> **NCT07485023** · NA · NOT_YET_RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 128 (estimated)

## Conditions studied

- Anemia Complicating Pregnancy

## Interventions

- **DRUG:** Oral iron supplementation
- **DRUG:** IV iron administration

## Key facts

- **NCT ID:** NCT07485023
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07485023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07485023, "Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07485023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*